Literature DB >> 19306943

Endoscopic therapy for Barrett's esophagus.

Richard E Sampliner1.   

Abstract

Recent retrospective cohort data and a prospective randomized sham controlled trial have clearly documented the impact of endoscopic ablation therapy on dysplasia and Barrett's esophagus (BE). The clinical indications for ablation of BE includes high-grade dysplasia and intramucosal adenocarcinoma. The techniques of resection of mucosal irregularities and of ablation are reviewed, primarily thermal and photodynamic ablation. Ablation of BE with neoplasia has appropriately entered the clinical arena.

Entities:  

Mesh：

Year:  2009        PMID： 19306943     DOI： 10.1016/j.cgh.2009.03.011

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


  4 in total

1.  Low prevalence of invasive adenocarcinoma and occult cancer on esophageal resection for Barrett's esophagus with high-grade dysplasia: Evidence for conservative management.

Authors:  Deepa T Patil; Thomas P Plesec; John R Goldblum
Journal:  J Gastrointest Oncol       Date:  2011-03

2.  Predictors of esophageal stricture formation post endoscopic mucosal resection.

Authors:  Bashar Qumseya; Abraham M Panossian; Cynthia Rizk; David Cangemi; Christianne Wolfsen; Massimo Raimondo; Timothy Woodward; Michael B Wallace; Herbert Wolfsen
Journal:  Clin Endosc       Date:  2014-03-31

Review 3.  History, molecular mechanisms, and endoscopic treatment of Barrett's esophagus.

Authors:  Stuart Jon Spechler; Rebecca C Fitzgerald; Ganapathy A Prasad; Kenneth K Wang
Journal:  Gastroenterology       Date:  2010-01-18       Impact factor: 22.682

4.  Photodynamic Therapy for Barrett's Esophagus and Esophageal Carcinoma.

Authors:  Bashar J Qumseya; Waseem David; Herbert C Wolfsen
Journal:  Clin Endosc       Date:  2013-01-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.